- Published: Saturday, 21 May 2016 09:20
- Written by Rebecca Reza
Targeting the 2021 Tour de France
Team Novo Nordisk is competing in their third consecutive AMGEN Tour of California this week. Heading into the final two days of racing, the team’s best placed rider is veteran, Javier Megias, siting 16th on GC.
Originally named, Team Type 1, the team was founded in 2008. Novo Nordisk came on board in 2012, when the squad switched to an all-type 1 diabetes roster. The mission continues to be one of inspiration and education, working with Novo Nordisk to learn what is possible and how to manage diabetes for athletes.
USCR spoke with CEO and Co-Founder of the team, Phil Southerland, before the start in South Pasadena earlier this week about the team’s goals and aspirations for the rest of the season.
USCR's Rebecca Reza talks with Team Novo Nordisk' Phil Southerland.